Aitor Benedicto

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Replacement Therapy

Cell Proliferation

Top Venues

Pharmaceuticals (Basel, Switzerland)

The breast journal

This page only lists publications with an associated author ORCID identifier.

Publications

Aitor Benedicto, Beatriz Arteta, Andrea Duranti, Daniel Alonso-Alconada
The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Irene Romayor, Marina Luque García-Vaquero, Joana Márquez, Beatriz Arteta, Ramón Barceló, Aitor Benedicto
Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer. The breast journal 2022 (2022)